メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Novel heterozygous mutation in TBX1 in an infant with hypocalcemic seizures

  • Kosei Hasegawa
  • , Hiroyuki Tanaka
  • , Yousuke Higuchi
  • , Yumiko Hayashi
  • , Katsuhiro Kobayashi
  • , Hirokazu Tsukahara

研究成果査読

抄録

Patients with 22q11.2 deletion syndrome have characteristic facial appearance, palate abnormalities, hypoparathyroidism, thymic hypoplasia, and congenital heart disease. The 22q11.2 region includes TBX1 and 30 other genes. Analysis of Tbx1 transgenic mice showed that TBX1 was associated with the 22q11.2 deletion syndrome. In humans, TBX1 mutations have been reported in 22q11.2 deletion-negative patients with velocardiofacial syndrome or DiGeorge syndrome. Genotype-phenotype correlations are not fully understood in these patients. We report the case of an infant with a novel heterozygous TBX1 mutation who experienced hypocalcemic seizures. This patient had no palate abnormalities, cardiac anomalies, or the typical facial appearance observed in 22q11.2 deletion syndrome. The presence of thymic hypoplasia prompted us to perform G-banding, fluorescent in situ hybridization, and subsequent TBX1 analysis. We emphasize the importance of diagnosing thymic hypoplasia in hypocalcemic infants without 22q11.2 deletion for detecting TBX1 mutations.

本文言語English
ページ(範囲)159-164
ページ数6
ジャーナルclinical pediatric endocrinology
27
3
DOI
出版ステータスPublished - 2018

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

ASJC Scopus subject areas

  • 小児科学、周産期医学および子どもの健康
  • 内分泌学、糖尿病および代謝内科学
  • 内分泌学

フィンガープリント

「Novel heterozygous mutation in TBX1 in an infant with hypocalcemic seizures」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル